| 研究課題/領域番号 |
22K13423
|
|---|
| 研究種目 |
若手研究
|
| 配分区分 | 基金 |
|---|
| 審査区分 |
小区分07050:公共経済および労働経済関連
|
|---|
| 研究機関 | 早稲田大学 |
|---|
研究代表者 |
富 蓉 早稲田大学, 商学学術院, 准教授 (70805259)
|
|---|
| 研究期間 (年度) |
2022-04-01 – 2026-03-31
|
| 研究課題ステータス |
交付 (2023年度)
|
| 配分額 *注記 |
4,420千円 (直接経費: 3,400千円、間接経費: 1,020千円)
2025年度: 780千円 (直接経費: 600千円、間接経費: 180千円)
2024年度: 780千円 (直接経費: 600千円、間接経費: 180千円)
2023年度: 1,170千円 (直接経費: 900千円、間接経費: 270千円)
2022年度: 1,690千円 (直接経費: 1,300千円、間接経費: 390千円)
|
|---|
| キーワード | generic drugs |
|---|
| 研究開始時の研究の概要 |
we aim to assess if the incentives influence physicians' and pharmacies' willingness to prescribe and dispense generics. Furthermore, we expect to determine (2) whether the policies encouraged physicians to prescribe generics; (3) whether the policies motivated pharmacists to dispense generics.
|
| 研究実績の概要 |
In 2023, we investigated the importance of the interplay between physician, pharmacist, and patient in generic drug use. We aim to contribute to the existing literature by exploring several key questions: Does a closer affiliation between hospitals and pharmacies, namely hospital-based pharmacies, correlate with increased GE usage? Does the establishment of a robust patient-pharmacy rapport, often observed in community-based pharmacies, facilitate greater GE adoption? Furthermore, how do these relationships between hospitals, patients, and pharmacies differ based on pharmacy characteristics? Lastly, of significant importance, is there an interaction between hospital-pharmacy affiliations and patient-pharmacy associations in influencing GE adoption?
|
| 現在までの達成度 (区分) |
現在までの達成度 (区分)
3: やや遅れている
理由
The slight delay in the progress of this research project is due to a combination of unforeseen challenges. Particularly, coordinating schedules with interdisciplinary collaborators and securing ethical approvals proved more time-consuming than expected, as did refining the participant recruitment strategy.The lingering logistical impacts of the COVID-19 pandemic also moderately contributed to scheduling delays for key experimental procedures.
|
| 今後の研究の推進方策 |
To improve interdisciplinary coordination, a dedicated project coordinator has been assigned, digital collaboration tools have been implemented, and structured meetings now streamline communication. Also, we’ve adjusted our laboratory scheduling to be more flexible, identified alternative spaces to avoid bottlenecks, and maintained strict safety protocols to mitigate pandemic-related impacts.
|
